{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:01:18Z","timestamp":1788415278070,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.toxicon.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T18:50:58Z","timestamp":1632336658000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Varespladib (LY315920) prevents neuromuscular blockage and myotoxicity induced by crotoxin on mouse neuromuscular preparations"],"prefix":"10.1016","volume":"202","author":[{"given":"Fernanda Valadares","family":"Maciel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-2135","authenticated-orcid":false,"given":"\u00camylle Karoline","family":"Ramos Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Muradas","family":"Val\u00e9rio Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales Augusto","family":"Gon\u00e7alves de Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Ladeira","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-5108","authenticated-orcid":false,"given":"Consuelo Latorre","family":"Fortes-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-636X","authenticated-orcid":false,"given":"Walter Lu\u00eds","family":"Garrido Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2021.09.009_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/toxins12020068","article-title":"Amplification of snake venom toxicity by endogenous signaling pathways","volume":"12","author":"Bickler","year":"2020","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.toxicon.2021.09.009_bib2","first-page":"439","article-title":"Crotoxin, half-century of investigations on a phospholipase A2 neurotoxin","volume":"39","author":"Bon","year":"1989","journal-title":"Acta Physiol. Pharmacol. Latinoam."},{"key":"10.1016\/j.toxicon.2021.09.009_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1432-1033.1979.tb13278.x","article-title":"Postsynaptic effects of crotoxin and of its isolated subunits","volume":"99","author":"Bon","year":"1979","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2021.09.009_bib4","first-page":"417","article-title":"A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis","volume":"32","author":"Bradley","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxicon.2021.09.009_bib5","first-page":"34","article-title":"Action of crotoxin and crotactin from the venom of Crotalus durissus terrificus (South American rattlesnake) on the frog neuromuscular junction","volume":"212","author":"Brazil","year":"1971","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2021.09.009_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1432-1033.1974.tb03838.x","article-title":"Biochemistry and pharmacology of the Crotoxin complex: biochemical analysis of Crotapotin and the basic Crotalus phospholipase A","volume":"49","author":"Breithaupt","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2021.09.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.11.292","article-title":"Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2","volume":"157","author":"Bryan-Quir\u00f3s","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib8","series-title":"Animais Pe\u00e7onhentos no Brasil: biologia, cl\u00ednica e terap\u00eautica dos acidentes","author":"Cardoso","year":"2009"},{"key":"10.1016\/j.toxicon.2021.09.009_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2017.08.021","article-title":"Neuromuscular paralysis by the basic phospholipase A2 subunit of crotoxin from Crotalus durissus terrificus snake venom needs its acid chaperone to concurrently inhibit acetylcholine release and produce muscle blockage","volume":"334","author":"Cavalcante","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.09.009_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxicon.2015.01.006","article-title":"Neuromuscular effects of venoms and crotoxin-like proteins from Crotalus durissus ruruima and Crotalus durissus cumanensis","volume":"96","author":"Cavalcante","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00508469","article-title":"Crotoxin, the neurotoxin of South American rattlesnake venom, is a presynaptic toxin acting like \u03b2-bungarotoxin","volume":"296","author":"Chang","year":"1977","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.09.009_bib12","doi-asserted-by":"crossref","first-page":"10708","DOI":"10.1021\/bi00091a022","article-title":"Model for the interaction of Crotoxin, a phospholipase A2 neurotoxin, with presynaptic membranes","volume":"32","author":"D\u00e9lot","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2021.09.009_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/bi00402a036","article-title":"A phospholipase A2 neurotoxin from the South American rattlesnake Crotalus durissus terrificus: purification of several isoforms and comparison of their molecular structure and of their biological activities","volume":"27","author":"Faure","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2021.09.009_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1432-1033.1976.tb10833.x","article-title":"Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties","volume":"68","author":"Fohlman","year":"1976","journal-title":"Eur. J. Biochem."},{"issue":"22","key":"10.1016\/j.toxicon.2021.09.009_bib15","doi-asserted-by":"crossref","first-page":"15646","DOI":"10.1016\/S0021-9258(17)40730-7","article-title":"A phospholipase A2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). Protein structure, genomic structure, and mechanism of action","volume":"269","author":"Fortes-Dias","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2021.09.009_bib16","first-page":"1345923","article-title":"Clinical, laboratory, and therapeutic aspects of Crotalus durissus (south American rattlesnake) victims: a literature review","volume":"5","author":"Frare","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"10","key":"10.1016\/j.toxicon.2021.09.009_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/toxins10040170","article-title":"Snakebite: when the human touch becomes a bad touch","volume":"21","author":"Fry","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.09.009_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOL.0b013e32832dd4c7","article-title":"Phospholipase A2 inhibitors","volume":"20","author":"Garcia-Garcia","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.toxicon.2021.09.009_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0041-0101(84)90162-4","article-title":"Morphological changes induced by Crotoxin in murine nerve and neuromuscular junction","volume":"22","author":"Gopalakrishnakone","year":"1984","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/toxins13070451","article-title":"The search for natural and synthetic inhibitors that would complement antivenoms as therapeutics for snakebite envenoming","volume":"13","author":"Guti\u00e9rrez","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.09.009_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/toxins12020131","article-title":"Varespladib (LY315920) and methyl Varespladib (LY333013) abrogate or delay lethality induced by presynaptically acting neurotoxic snake venoms","volume":"12","author":"Guti\u00e9rrez","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.09.009_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0041-0101(78)90056-9","article-title":"The Crotoxin complex-an example of biochemical and pharmacological protein complementation","volume":"16","author":"Habermann","year":"1978","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib23","first-page":"3","article-title":"Snake venom presynaptic toxins","volume":"vol. 5","author":"Hawgood","year":"1991"},{"key":"10.1016\/j.toxicon.2021.09.009_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0306-4522(79)90090-3","article-title":"Changes in spontaneous and evoked release of transmitter induced by the Crotoxin complex and its component phospholipase A2 at the frog neuromuscular junction","volume":"4","author":"Hawgood","year":"1979","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2021.09.009_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1476-5381.1977.tb07553.x","article-title":"The mode of action at the mouse neuromuscular junction of the phospholipase A\u2010crotapotin complex isolated from venom of the South American Rattlesnake","volume":"61","author":"Hawgood","year":"1977","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.toxicon.2021.09.009_bib26","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1073\/pnas.68.7.1560","article-title":"Biological roles of the two components of crotoxin","volume":"68","author":"Hendon","year":"1971","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.toxicon.2021.09.009_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1073\/pnas.75.2.600","article-title":"Search for relationships among the hemolytic, phospholipipolytic, and neurotoxic activities of snake venoms","volume":"75","author":"Jeng","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxicon.2021.09.009_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.09.009_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/toxins10100380","article-title":"Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan taipan (Oxyuranus scutellatus) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.09.009_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0163-7258(90)90081-C","article-title":"Myotoxic components of snake venoms: their biochemical and biological activities","volume":"48","author":"Mebs","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxicon.2021.09.009_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.toxicon.2003.10.029","article-title":"Membrane depolarization is the initial action of Crotoxin on isolated murine skeletal muscle","volume":"43","author":"Melo","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome. The VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxicon.2021.09.009_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxicon.2020.08.023","article-title":"LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation","volume":"187","author":"Oliveira","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0041-0101(98)00246-3","article-title":"Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and its main toxin","volume":"37","author":"Oshima-Franco","year":"1999","journal-title":"Crotoxin. Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S0104-42302001000100026","volume":"47","author":"Pinho","year":"2001","journal-title":"Ofidismo. Rev Assoc Med Bras"},{"key":"10.1016\/j.toxicon.2021.09.009_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.toxicon.2020.12.016","article-title":"Crotalus Neutralizing Factor (CNF) inhibits the toxic effects of Crotoxin at mouse neuromuscular preparations","volume":"191","author":"Pinto","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib37","article-title":"Symptomatology, pathology and treatment of snake bites in South America","volume":"vol. 2","author":"Rosenfeld","year":"1971"},{"key":"10.1016\/j.toxicon.2021.09.009_bib38","doi-asserted-by":"crossref","first-page":"129913","DOI":"10.1016\/j.bbagen.2021.129913","article-title":"The synthetic Varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins","volume":"1865","author":"Salvador","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.toxicon.2021.09.009_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41598-018-36839-6","article-title":"Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A2-like proteins using functional, structural and bioinformatics approaches","volume":"9","author":"Salvador","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2021.09.009_bib40","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.toxicon.2010.01.011","article-title":"Novel activities for a classic \u03b2-neurotoxin","volume":"55","author":"Sampaio","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.09.009_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0009044","article-title":"Overview of snakebite in Brazil: possible drivers and a tool for risk mapping","volume":"15","author":"Schneider","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2021.09.009_bib42","first-page":"153","article-title":"Cross-reactivity of horse monovalent antivenoms to venoms of ten Bothrops species","volume":"51","author":"Silva","year":"1989","journal-title":"Mem. Inst. Butantan (Sao Paulo)"},{"key":"10.1016\/j.toxicon.2021.09.009_bib43","first-page":"505","article-title":"Purifica\u00e7\u00e3o e cristaliza\u00e7\u00e3o do veneno da cobra cascavel","volume":"12","author":"Slotta","year":"1938","journal-title":"Mem. Inst. Butantan (Sao Paulo)"},{"key":"10.1016\/j.toxicon.2021.09.009_bib44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(24)38064-4","article-title":"Pharmacology of LY315920\/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy]acetate, a potent and selective secretory phospholipase A2 inhibitor: a new class of anti-inflammatory drugs","volume":"288","author":"Snyder","year":"1999","journal-title":"SPI. J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2021.09.009_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.atherosclerosis.2010.03.011","article-title":"Phospholipase A2s: developing drug targets for atherosclerosis","volume":"212","author":"Suckling","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.toxicon.2021.09.009_bib46","first-page":"981","article-title":"Pharmacology of crystalline crotoxin II. Neuromuscular blocking action","volume":"33","author":"Vital Brazil","year":"1966","journal-title":"Mem. Inst. Butantan (Sao Paulo)"},{"key":"10.1016\/j.toxicon.2021.09.009_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/molecules23020391","article-title":"Exploration of the inhibitory potential of Varespladib for snakebite envenomation","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2021.09.009_bib48","series-title":"The Venomous Reptiles of the Western Hemisphere","first-page":"709","article-title":"Snakebites in Central and South America: epidemiology, clinical features, and clinical management","author":"Warrel","year":"2004"},{"key":"10.1016\/j.toxicon.2021.09.009_bib49","series-title":"Snakebite","year":"2021"},{"key":"10.1016\/j.toxicon.2021.09.009_bib50","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/molecules23081911","article-title":"Inactivation of venom PLA2 alleviates myonecrosis and facilitates muscle regeneration in envenomed mice: a time course observation","volume":"23","author":"Xiao","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2021.09.009_bib51","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/01.CCM.0000171540.54520.69","article-title":"EZZI Study Group. LY315920NA\/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis","volume":"33","author":"Zeiher","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.toxicon.2021.09.009_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/toxins12060356","article-title":"PLA2 inhibitor Varespladib as an alternative to the antivenom treatment for bites from nikolsky's viper Vipera berus nikolskii","volume":"12","author":"Zinenko","year":"2020","journal-title":"Toxins"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:18:58Z","timestamp":1758575938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010121002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":52,"alternative-id":["S0041010121002579"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.09.009","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varespladib (LY315920) prevents neuromuscular blockage and myotoxicity induced by crotoxin on mouse neuromuscular preparations","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}